Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
US8952162B2 · kind B2 · utility
3Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2009 |
| Grant date | Feb 10, 2015 |
| Priority date | — |
| Expiry date | Dec 22, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound according to formula I, wherein R1, R2 and A are as defined herein, which exhibit PDE4 inhibitory activity and may be used in the treatment of inflammatory diseases or autoimmune diseases, in particular inflammatory or proliferative dermal diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.